Article
11 Jun 2026
FDA Issues Draft Guidance On Payor Communications To Address Statutory Changes
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
24 May 2026
FDA Renews Focus On Drug Repurposing With New RFI
Article
22 May 2026
CMS ‘Crackdown On Fraud’ Continues With Nationwide Six-Month Moratoria On New Medicare Enrollments For Hospices And Home Health Agencies
Article
19 May 2026
Rethinking The Pantry: FDA Finalizes Post‑Market Plan For Food Chemicals And Initiates Reassessments Of BHT And ADA
Article
13 May 2026
FDA Seeks Feedback On Patient-Focused Drug Development
Article
06 May 2026
FDA Makes Moves To Modernize Drug Development, Clinical Trial Paradigm
Article
24 Apr 2026
Ambitious Priorities: Breaking Down FDA’s FY27 Budget
Article
13 Apr 2026
FDA Dives Deeper Into The Use Of Digital Health Technologies In Drug Development With New RFI
Article
07 Apr 2026
FDA Presses Forward On Incorporating Patient Preferences In Device Decision Making, Releases Updated Final Guidance
Article
27 Mar 2026
FDA Announces Public Hearing And Opportunity To Comment On National Priority Voucher Pilot Program
Article
25 Mar 2026
FDA And NIH Take Actions To Reduce Reliance On Animal Testing With New Draft Guidance And Funding Announcement
Article
19 Mar 2026
Q&A: FDA Seeks To Clarify '3-Year Exclusivity' With New Guidance
Article
03 Mar 2026
HHS Kicks Off Rare Disease Week With FDA Release Of Draft Guidance On Plausible Mechanism Framework For Individualized Therapies
Article
24 Feb 2026
Congress Rallies To Extend Rare Pediatric Disease Priority Review Voucher Program
Article
10 Feb 2026
PBM Reform Picks Up Pace With Enactment Of Consolidated Appropriations Act, PBM Fee Disclosure Proposed Rule
Article
09 Jan 2026
CMS Launches Five New Models At The End Of 2025: Looks To Advance ACCESS, BALANCE, MAHA ELEVATE, GLOBE And GUARD In 2026
Article
09 Jan 2026
FDA Issues Key Guidance Updates For Digital Health And Wellness
Article
19 Dec 2025
FDA's TEMPO Pilot Seeks To Expand Access To Chronic Disease Technologies In CMS Collaboration
Article
21 Nov 2025
An Overview Of The Over-the-Counter Monograph Drug User Fee Amendments (OMUFA): Policy Areas To Watch
Article
10 Nov 2025
FDA Issues Draft Guidance With Updated Recommendations For Assessing The Need For Comparative Efficacy Studies In Biosimilar Development